Dustin S. Sjuts - Jun 30, 2023 Form 4 Insider Report for Revance Therapeutics, Inc. (RVNC)

Role
President
Signature
/s/ Dwight Moxie, Attorney-in-Fact
Stock symbol
RVNC
Transactions as of
Jun 30, 2023
Transactions value $
$15,606
Form type
4
Date filed
7/5/2023, 09:11 PM
Previous filing
Jun 13, 2023
Next filing
Aug 15, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RVNC Common Stock Award $15.6K +1K +0.68% $15.61 148K Jun 30, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were acquired by Mr. Sjuts under the Issuer's 2014 Employee Stock Purchase Plan on June 30, 2023 in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).